The evaluation of the hERG channel blockage potential is essential for the drug development process as the channel blockage caused prolongation of QT interval (duration from ventricular depolarization to repolarization) which may lead to cardiac arrhythmias or irregular heartbeat25. Here, KCNH2 is linked to cardiac rhythm disease.